Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients
Abstract Coronavirus disease 2019 (COVID-19) is a highly contagious disease that appeared in China in December 2019 and spread rapidly around the world. Several patients with severe COVID-19 infection can develop a coagulopathy according to the ISTH criteria for disseminated intravascular coagulopat...
Guardado en:
Autores principales: | Alberto Polimeni, Isabella Leo, Carmen Spaccarotella, Annalisa Mongiardo, Sabato Sorrentino, Jolanda Sabatino, Salvatore De Rosa, Ciro Indolfi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9242a475815549bebbb0449e5d2da220 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Measurement of the QT interval using the Apple Watch
por: Carmen Anna Maria Spaccarotella, et al.
Publicado: (2021) -
MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts.
por: Antonio Curcio, et al.
Publicado: (2013) -
TEG<sup>®</sup>, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy
por: Gert Jacobus Laubscher, et al.
Publicado: (2021) -
Platelet-Mediated NET Release Amplifies Coagulopathy and Drives Lung Pathology During Severe Influenza Infection
por: Seok-Joo Kim, et al.
Publicado: (2021) -
Asymptomatic versus Symptomatic Patients with Severe Aortic Stenosis
por: Norio Kanamori, et al.
Publicado: (2018)